{"count": 1, "results": [{"_id": "20564343", "pmid": 20564343, "title": "Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.", "journal": "Mol Carcinog", "authors": ["Hosono K", "Endo H", "Takahashi H", "Sugiyama M", "Uchiyama T", "Suzuki K", "Nozaki Y", "Yoneda K", "Fujita K", "Yoneda M", "Inamori M", "Tomatsu A", "Chihara T", "Shimpo K", "Nakagama H", "Nakajima A"], "date": "2010-07-01T00:00:00Z", "doi": "10.1002/mc.20637", "meta_date_publication": "2010 Jul", "meta_volume": "49", "meta_issue": "7", "meta_pages": "662-71", "score": 50060.133, "text_hl": "Treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ significantly reduced @<m>DISEASE_Cayler_cardiofacial_syndrome</m> @DISEASE_MESH:C535349 @@@ACF@@@ formation. ", "citations": {"NLM": "Hosono K, Endo H, Takahashi H, Sugiyama M, Uchiyama T, Suzuki K, Nozaki Y, Yoneda K, Fujita K, Yoneda M, Inamori M, Tomatsu A, Chihara T, Shimpo K, Nakagama H, Nakajima A. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. Mol Carcinog. 2010 Jul;49(7):662-71. PMID: 20564343", "BibTeX": "@article{20564343, title={Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.}, author={Hosono K and Endo H and Takahashi H and Sugiyama M and Uchiyama T and Suzuki K and Nozaki Y and Yoneda K and Fujita K and Yoneda M and Inamori M and Tomatsu A and Chihara T and Shimpo K and Nakagama H and Nakajima A}, journal={Mol Carcinog}, volume={49}, number={7}, pages={662-71}}"}}]}